The Lancet|Long COVID: a clinical update

Long COVID: a clinical update 

Trisha Greenhalgh, Manoj Sivan, Alice Perlowski, Janko Ž Nikolich

Lancet 2024; 404: 707–24

DOI: 10.1016/S0140-6736(24)01136-X

 

Summary

Post-COVID-19 condition (also known as long COVID) is generally defined as symptoms persisting for 3 months or more after acute COVID-19. Long COVID can affect multiple organ systems and lead to severe and protracted impairment of function as a result of organ damage. The burden of this disease, both on the individual and on health systems and national economies, is high. In this interdisciplinary Review, with a coauthor with lived experience of severe long COVID, we sought to bring together multiple streams of literature on the epidemiology, pathophysiology (including the hypothesised mechanisms of organ damage), lived experience and clinical manifestations, and clinical investigation and management of long COVID. Although current approaches to long COVID care are largely symptomatic and supportive, recent advances in clinical phenotyping, deep molecular profiling, and biomarker identification might herald a more mechanism-informed and personally tailored approach to clinical care. We also cover the organisation of services for long COVID, approaches to preventing long COVID, and suggestions for future research.

img1

img2

img3

img4

img5

img6

img7

img8

首页标题    科研进展    The Lancet|Long COVID: a clinical update